Résultats de la recherche - Zhuang, Aowen
- Résultat(s) 1 - 10 résultats de 10
-
1
Globally elevating the AGE clearance receptor, OST48, does not protect against the development of diabetic kidney disease, despite improving insulin secretion par Zhuang, Aowen, Yap, Felicia Y. T., McCarthy, Domenica, Leung, Chris, Sourris, Karly C., Penfold, Sally A., Thallas-Bonke, Vicki, Coughlan, Melinda T., Schulz, Benjamin L., Forbes, Josephine M.
Publié 2019Texte -
2
The AGE receptor, OST48 drives podocyte foot process effacement and basement membrane expansion (alters structural composition) par Zhuang, Aowen, Yap, Felicia Y. T., Borg, Danielle J., McCarthy, Domenica, Fotheringham, Amelia, Leung, Sherman, Penfold, Sally A., Sourris, Karly C., Coughlan, Melinda T., Schulz, Benjamin L., Forbes, Josephine M.
Publié 2021Texte -
3
Perinatal exposure to high dietary advanced glycation end products in transgenic NOD8.3 mice leads to pancreatic beta cell dysfunction par Borg, Danielle J., Yap, Felicia Y. T., Keshvari, Sahar, Simmons, David G., Gallo, Linda A., Fotheringham, Amelia K., Zhuang, Aowen, Slattery, Robyn M., Hasnain, Sumaira Z., Coughlan, Melinda T., Kantharidis, Phillip, Forbes, Josephine M.
Publié 2017Texte -
4
SOD2 in skeletal muscle: New insights from an inducible deletion model par Zhuang, Aowen, Yang, Christine, Liu, Yingying, Tan, Yanie, Bond, Simon T., Walker, Shannen, Sikora, Tim, Laskowski, Adrienne, Sharma, Arpeeta, de Haan, Judy B., Meikle, Peter J., Shimizu, Takahiko, Coughlan, Melinda T., Calkin, Anna C., Drew, Brian G.
Publié 2021Texte -
5
Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice par Gallo, Linda A., Ward, Micheal S., Fotheringham, Amelia K., Zhuang, Aowen, Borg, Danielle J., Flemming, Nicole B., Harvie, Ben M., Kinneally, Toni L., Yeh, Shang-Ming, McCarthy, Domenica A., Koepsell, Hermann, Vallon, Volker, Pollock, Carol, Panchapakesan, Usha, Forbes, Josephine M.
Publié 2016Texte -
6
Erratum: Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice par Gallo, Linda A., Ward, Micheal S., Fotheringham, Amelia K., Zhuang, Aowen, Borg, Danielle J., Flemming, Nicole B., Harvie, Ben M., Kinneally, Toni L., Yeh, Shang-Ming, McCarthy, Domenica A., Koepsell, Hermann, Vallon, Volker, Pollock, Carol, Panchapakesan, Usha, Forbes, Josephine M.
Publié 2016Texte -
7
Increased liver AGEs induce hepatic injury mediated through an OST48 pathway par Zhuang, Aowen, Yap, Felicia YT., Bruce, Clinton, Leung, Chris, Plan, Manuel R., Sullivan, Mitchell A., Herath, Chandana, McCarthy, Domenica, Sourris, Karly C., Kantharidis, Phillip, Coughlan, Melinda T., Febbraio, Mark A., Hodson, Mark P., Watt, Matthew J., Angus, Peter, Schulz, Benjamin L., Forbes, Josephine M.
Publié 2017Texte -
8
Targeted mitochondrial therapy using MitoQ shows equivalent renoprotection to angiotensin converting enzyme inhibition but no combined synergy in diabetes par Ward, Micheal S., Flemming, Nicole B., Gallo, Linda A., Fotheringham, Amelia K., McCarthy, Domenica A., Zhuang, Aowen, Tang, Peter H., Borg, Danielle J., Shaw, Hannah, Harvie, Benjamin, Briskey, David R., Roberts, Llion A., Plan, Manuel R., Murphy, Michael P., Hodson, Mark P., Forbes, Josephine M.
Publié 2017Texte -
9
Tissue-specific expression of Cas9 has no impact on whole-body metabolism in four transgenic mouse lines par Bond, Simon T., Zhuang, Aowen, Yang, Christine, Gould, Eleanor A.M., Sikora, Tim, Liu, Yingying, Fu, Ying, Watt, Kevin I., Tan, Yanie, Kiriazis, Helen, Lancaster, Graeme I., Gregorevic, Paul, Henstridge, Darren C., McMullen, Julie R., Meikle, Peter J., Calkin, Anna C., Drew, Brian G.
Publié 2021Texte -
10
Loss of the long non-coding RNA OIP5-AS1 exacerbates heart failure in a sex-specific manner par Zhuang, Aowen, Calkin, Anna C., Lau, Shannen, Kiriazis, Helen, Donner, Daniel G., Liu, Yingying, Bond, Simon T., Moody, Sarah C., Gould, Eleanor A.M., Colgan, Timothy D., Carmona, Sergio Ruiz, Inouye, Michael, de Aguiar Vallim, Thomas Q., Tarling, Elizabeth J., Quaife-Ryan, Gregory A., Hudson, James E., Porrello, Enzo R., Gregorevic, Paul, Gao, Xiao-Ming, Du, Xiao-Jun, McMullen, Julie R., Drew, Brian G.
Publié 2021Texte